Article info

Download PDFPDF
Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trial

Authors

  1. Correspondence to Dr Lai-Shan Tam, Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong; lstam{at}cuhk.edu.hk
View Full Text

Citation

So H, Cheng IT, Lau S, et al
Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trial

Publication history

  • Received January 4, 2021
  • Revised February 21, 2021
  • Accepted March 18, 2021
  • First published April 2, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.